Colorectal Cancer Control and Prevention
12
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Life Expectancy-informed Colorectal Cancer Screening
Optical Diagnosis of Neoplasia Using Artificial Intelligence
Effect of Static vs. Conversational AI-Generated Messages on Colorectal Cancer Screening Intent: a Randomized Controlled Trial
Prophylactic PIPAC in Patients With High-risk Colorectal Cancer
[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy
Implementation of an Efferent Loop Stimulation Protocol Prior to Ileostomy Closure at La Paz University Hospital
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
Appropriateness of Colonoscopy Indication: an Evaluation of the Clinical and Economic Impact.
6-year Follow-up Data After the Berberine Intervention Trial
Clinical and Endoscopic Characterization of Patients With Multiple Colorectal Adenomas: A Multicenter Study in Spain (ESPAPOLYP Study)
Effectiveness of a PMT Intervention to Reduce Alcohol in Young Adults
Beans/Bran Enriching Nutritional Eating For Intestinal Health Trial